Pricing
Pricing per document, per axis, by page volume and, for scientific review, by reference count. Price shown before validation.
EryonOne
Use cases Pharma and ANSM
Review your pharma promotional materials
EryonOne helps marketing, medical and regulatory teams spot sensitive passages in a healthcare asset before human arbitration, internal validation or submission.
01 Benefits
What EryonOne helps prepare
Therapeutic or comparative claims
Spot wording to secure, comparisons to document and passages that need regulatory or medical validation.
Consistency with references
Compare the asset with provided documents such as SmPC, MA, opinions or bibliography to identify discrepancies to examine.
Benefit / risk balance
Flag areas where benefits, limits, precautions or important mentions seem insufficiently visible.
02 Use cases
Use cases
Pharmaceutical companies preparing an internal review.
Healthcare agencies adapting content to the French market.
International teams wanting to structure marketing, medical and regulatory exchanges.
03 Limits
An assistant, not a regulatory authorisation
EryonOne is an assistant, not a validator. Business responsibility (regulatory, medical, quality, legal) stays with your teams. The report is working material, not an approval.
Frequently asked questions
Your questions about this use case
Does EryonOne deliver an ANSM approval?
No. EryonOne helps prepare the review of an asset, but replaces neither the competent authority nor internal regulatory validation.
Which promotional materials can be reviewed?
For now, review is available on PDF. Word and PowerPoint come next. Detail aids, brochures, e-mailings, web pages, presentations, product sheets or scripts must therefore be provided as PDF.
Can the tool compare an asset with the SmPC or MA?
Yes, if the reference documents are provided. EryonOne helps spot discrepancies or points to arbitrate.
Who makes the final decision?
Regulatory, medical or legal teams always keep the final say.